E-Prescribing
Integrated workflows ease staff burden and satisfy regulatory mandates.
Blog
E-Prescribing of Controlled Substances: We’re doing that!
DrFirst
February 25, 2020
|
2
min read
Education Session 176
Initial Experience with E-Prescribing of Controlled Substances: How It’s Done
Wednesday, March 3, 1:00 PM – 2:00 PM
http://www.himssconference.org/education/sessiondetail.aspx?eventID=3732
I’m excited to let you know that our CMO, Peter Kaufman, MD is set to co-host one of the HIMSS education sessions titled, Initial Experience with E-Prescribing of Controlled Substances: How It’s Done.
For about a year and a half now, DrFirst has been working very hard to overcome the final major barrier to widespread adoption of e-prescribing: the problem of controlled substances and the DEA’s need to ensure it can enforce relevant laws in an electronic environment. We set out to demonstrate that although the DEA has numerous concerns, we have the technology and capability to make the process efficient, secure, and safe.
Under a waiver from the DEA, we have worked closely with the Massachusetts Department of Public Health (MDPH) and ERx Network to implement our security protocol within pharmacy and physician software—along with the network which connects them—to conduct a pilot program allowing outpatient centers to electronically prescribe controlled substances. In September 2009, Berkshire Medical Group, sent the nation’s first DEA-approved prescription of a controlled substance electronically, using DrFirst’s e-prescribing application, Rcopia. This one prescription was a huge milestone in the ongoing advancements in electronic prescribing, and has helped pave the road for others to see How It’s Done!
Session discussion points:
- The current state of e-prescribing of controlled substances
- Explain the impact of the prohibition of e-prescribing controlled substances on practice workflow and e-prescribing adoption
- Describe the Drug Enforcement Administration’s security concerns
- Identify and plan for overcoming barriers to adoption of e-prescribing controlled substances
- Identify the productivity gains associated with a single workflow for all prescribing
This is a must see event at this year’s HIMSS conference! We hope to see you there!
G. Cameron Deemer
